Posaconazole Tablet, Delayed Release
Product Images NDC 59651-596

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 59651-596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (100 mg (60 Tablets Bottle))

This is a description of Posaconazole Delayed-Release Tablets with NDC 59651-596-60. It is emphasized that Noxafil oral suspension and these tablets are not interchangeable due to dosing differences. Each tablet contains 100 mg of Posaconazole. The recommended storage temperature is 20° to 25°C. Usual dosage instructions can be found in the package insert. The product is distributed by Aurohindo Pharma USA, Inc. and manufactured in India. The text also includes information about trademarks and a code: TS/DRUGS/22/2009 P1428686.*

FDA Label Image

Str (Posaconazole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.